Puma Biotechnology Inc (PBYI)
Puma Biotechnology Inc (PBYI) is a NASDAQ-listed healthcare company in the biotechnology industry. Puma Biotechnology Inc common stock is an equity security, so the listed instrument represents a share of ownership in the company rather than a separate fund or debt issue. The business is associated with the development and commercialization of therapies for cancer care, with a focus on oncology-related research and product activity. As a common stock listing on NASDAQ, the security reflects the market trading of the company’s ordinary shares and is tied to the performance and prospects of the underlying business.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-PBYI
|
$11.96
|
21.8% Upside
|
Undervalued
|
$6
|
-38.9% Downside
|
Overvalued
|
Great
|
0.0%
|
October 29, 2026
|
19.0x
|
3.7x
|
2.2x
|
506.9 M
|
417.8 M
|
0.9%
|
76.8%
|
-3.0
|
154.0%
|
